HEALTHARATUS BETA

The intelligence layer is actively learning.

Back
Company

TrialJectory

vendor1 tracked tool

Company Intelligence

Leal Health Study Reveals Prostate Cancer Patients More Actively Engaged in Seeking Clinical Trials Significantly Earlier in Their Journey Compared to Other Solid Tumor Patients

3 days agoevidence

Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform

8 days agoevidence

Leal Health adds 'first' with FDA-approved cancer treatment decision support service

17 days agofda

TrialJectory Rebrands to Leal Health

17 days agoevidence

Bridging the gap: Leveraging AI to enhance access to clinical trials for underrepresented and underserved populations with cancer.

a month agoevidence

Can an artificial intelligence-based platform reduce physician burden and increase access to clinical trials?

a month agoevidence

TrialJectory and OncoBay Clinical Partner to Connect All Cancer Patients to Advanced Treatment Options

a month agoevidence

Leal Health Launches Predictive Patient Journey Solution

a month agoevidence

Leal Health Becomes Industry's First and Only Single Point of Access to FDA-Approved Treatments and Clinical Trials for Cancer Patients

a month agofda

Can an artificial intelligence-based platform reduce physician burden and increase access to clinical trials?

a month agoevidence

Leal Health Becomes Industry's First and Only Single Point of Access to FDA-Approved Treatments and Clinical Trials for Cancer Patients

2 months agofda

Leal Health Launches Proprietary Platform for Oncologists to Obtain Personalized Clinical Trial Matches for Patients

2 months agoevidence

AI is secret weapon for cancer trial recruitment and engagement, says TrialJectory CEO

2 months agoevidence

Leal Health establishes proprietary platform for oncologists to obtain personalized clinical trial matches for patients

2 months agoevidence

Trialjectory Grows Pharmaceutical and Biotech Clinical Trial Partnerships by 800 Percent

2 months agoevidence